Phase 3:
As a final phase to this engagement, the McKinsey team provided additional insights beyond the central objective by working with the client to identify potential revenue gaps and establish strategic priorities. Further, it helped define performance improvements required to boost sales and set specific operating targets to help the client track outcomes.

Summary
The client successfully licensed two late-stage compounds, each of which is expected to generate $200 to $300 million in U.S. sales.